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ABSTRACT 
The mitochondrial outer membrane 
(OM) contains single and multiple 
membrane-spanning proteins which 
need to contain signals that ensure 
correct targeting and insertion into the 
OM. The biogenesis of such proteins has 
so far essentially only been studied in 
yeast and related organisms. Here we 
show that POMP10, an OM protein of 
the early diverging protozoan 
Trypanosoma brucei, is signal-anchored. 
Transgenic cells expressing variants of 
POMP10 fused to GFP demonstrate 
that the N-terminal membrane-
spanning domain flanked by a few 
positively charged or neutral residues is 
both necessary and sufficient for 
mitochondrial targeting. Carbonate 
extraction experiments indicate that, 
while the presence of neutral instead of 
positively charged residues did not 
interfere with POMP10 localization, it 
weakened its interaction with the OM. 
Expression of GFP-tagged POMP10 in 
inducible RNAi cell lines shows that its 
mitochondrial localization depends on 
pATOM36 but does neither require 
Sam50 nor ATOM40, the trypanosomal 
analogue of the Tom40 import pore. 
pATOM36 is a kinetoplastid-specific 
OM protein that has previously been 
implicated in the assembly of OM 
proteins and in mitochondrial DNA 
inheritance. In summary, our results 
show that while the features of the 
targeting signal in signal-anchored 
proteins are widely conserved, the 
protein machinery that mediates their 
biogenesis is not.  
 Mitochondria perform many 
important functions and are essential for 
all eukaryotes (1). Whereas a small 
number of proteins are synthesized in the 
organelle, more than 95% of the 
mitochondrial proteome is nuclear-
encoded, synthesized in the cytosol and 
subsequently imported into mitochondria 
(2-4). Mitochondria consist of four 
compartments: the outer and the inner 
membrane that surround the soluble 
intermembrane space (IMS) and the 
matrix, respectively. Thus, nuclear-
encoded proteins not only need to be 
targeted to mitochondria but also sorted to 
their correct intra-mitochondrial 
destination. The mitochondrial outer 
membrane (OM) is of special interest. It 
builds the interface between the organelle 
and the cytosol and forms a barrier across 
which all communication between the 
organelle and its surroundings must occur 
(5-7). Mitochondrial OM proteins mediate 
apoptosis, fission and fusion, interaction 
with other organelles as well as transport 
of metabolites and precursor proteins. 
Whereas mitochondrial protein import in 
general has been extensively studied, we 
still have large gaps in the understanding 
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of the biogenesis of mitochondrial OM 
proteins (8-11).  
 Integral OM proteins are either 
anchored by a transmembrane β-barrel or 
by single or multiple α-helices. The single 
membrane-spanning proteins can further 
be categorized into N-terminal (signal)-
anchored, internally anchored or C-
terminal (tail)-anchored proteins. OM 
proteins generally contain internal 
targeting signals. For β-barrel proteins the 
OM targeting signal appears to be a 
dedicated β-hairpin motif (12), whereas 
for single membrane-spanning proteins the 
targeting signal is confined to the 
transmembrane domain and positive 
residues in its flanking regions (13-17). 
 Biogenesis of α-helically 
anchored OM proteins involves a number 
of import pathways, many of which are 
still poorly characterized. β-barrel proteins 
are first imported into the IMS by the 
translocase of the OM (TOM), where they 
bind to small translocase of the inner 
membrane (TIM) chaperones that hand 
them over to the sorting and assembly 
machinery (SAM) by which they are 
integrated into the OM (2,18). The 
insertion of some of the single membrane-
spanning OM proteins depends 
exclusively on TOM subunits. Tom22 on 
the other hand requires the TOM receptors 
but subsequently is inserted into the OM 
by SAM and Mdm10 (19). Finally, 
insertion of some OM proteins is mediated 
by a protein complex, consisting of Mim1 
and Mim2 (20-22), termed mitochondrial 
import (MIM) complex. The exact role of 
the MIM complex and its mode of action 
is still unknown (23). Moreover, it has 
recently been shown that a few proteins 
may be able to insert into the OM 
independently of protein factors and that at 
least in one case this is facilitated by 
specific lipids (24,25). 
 Mapping the variation of the 
import systems in different eukaryotes 
provides insight into the evolution of the 
mitochondrial protein import systems 
which is key to understand how the 
endosymbiotic ancestor of mitochondria 
converted into an organelle (26-29). 
However, most of what we know about 
mitochondrial protein import stems from 
work done in the yeast Saccharomyces 
cerevisiae and a few related organisms. 
 Here we have studied the 
biogenesis of POMP10 (present in the 
outer mitochondrial membrane proteome 
10) (7), a putative signal-anchored 
mitochondrial OM protein in the parasitic 
protozoan Trypanosoma brucei, which is 
essentially unrelated to yeast and one of 
the most early diverging eukaryotes 
(30,31). T. brucei has a mitochondrion that 
in the insect-stage of the parasite’s life 
cycle is capable of oxidative 
phosphorylation. In our study we have 
identified the features of the import signal 
of POMP10. Moreover, we show that its 
import is independent of both Sam50 and 
the trypanosomal functional analog of 
Tom40, termed archaic translocase of the 
mitochondrial OM 40 (ATOM40) (32-34). 
However, using RNAi-mediated ablation it 
could be demonstrated that the biogenesis 
of POMP10 does require the 
trypanosomatid-specific OM protein 
termed peripheral ATOM36 (pATOM36) 
that is loosely associated with the ATOM 
complex (35). pATOM36 has recently 
been shown to mediate assembly of the 
ATOM complex as well as mitochondrial 
DNA inheritance (36).  
 
RESULTS 
 POMP10 is a signal-anchored 
mitochondrial OM protein - POMP10 is 
an abundant mitochondrial OM protein 
that is conserved in all kinetoplastids and 
which in T. brucei has a predicted 
molecular weight of 62.2 kDa. It does 
neither have conserved domains nor 
orthologues outside the kinetoplastids. 
RNAi-mediated ablation of POMP10 
neither affects growth nor mitochondrial 
morphology (Fig. 1), its function therefore 
remains unknown. Most prediction 
programs indicate that POMP10 has a 
single  transmembrane domain at its very 
N-terminus (Table 1) that on both sides is 
flanked by positively charged amino acids 
(7). Bioinformatic analysis suggests it to 
be a signal-anchored protein, which would 
expose its soluble C-terminal domain to 
the cytosol. In order to experimentally 
confirm the predicted topology we 
produced a transgenic cell line expressing 
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a full length POMP10 variant whose C-
terminus is fused to GFP. Fig. 2A shows 
that the POMP10-GFP fusion is expressed 
and that during cell fractionation it 
behaves like the mitochondrial marker 
proteins. This was confirmed by 
immunofluorescence (IF) analysis which 
yields a staining pattern that is identical to 
the mitochondrial OM protein ATOM40 
(Fig. 4A). Protease protection assays using 
mitochondria isolated under isotonic 
conditions show that GFP-tagged 
POMP10 is protease-sensitive in intact 
mitochondria like the previously 
characterized protein import receptor 
ATOM69 (32). The IMS-localized 
TbTim9 and the matrix protein mtHsp70 
however were only digested after the 
membranes were dissolved by Triton (Fig. 
2B). 
 This indicates that the C-terminal 
soluble domain of the protein is exposed to 
the cytosol and thus establishes POMP10 
as a signal-anchored mitochondrial OM 
protein. The small TIM chaperone, TIM9, 
which serves as a soluble marker of the 
IMS, on the other hand is resistant to the 
treatment illustrating that the purified 
mitochondria that were used in the assay 
have an intact OM. Only when the 
membrane barrier is destroyed by the 
addition of detergent, TIM9 becomes 
susceptible to the treatment and gets 
degraded. 
 Transgenic cell lines expressing 
POMP10-GFP fusions - In order to 
identify the signal that directs POMP10 to 
the OM, we produced a series of 
transgenic cell lines that allow 
tetracycline-inducible expression of a 
number of POMP10 variants all of which 
were fused to GFP at their C-terminus. 
The variants include a deletion of the 
membrane-spanning domain as well as a 
series of constructs in which the soluble 
domain was replaced by GFP. The 
differences between the latter concerns 
point mutations which replace the 
positively charged amino acids of either 
the cytosolic or the IMS-exposed 
membrane-flanking regions with neutral or 
negatively charged amino acids, 
respectively. Moreover, in one variant all 
positively charged residues were deleted 
(Fig. 3A). The immunoblot analysis of 
whole cell  extracts from all transgenic cell 
lines using an anti-GFP antiserum shows 
that all POMP10-GFP fusions are 
expressed at comparable levels (Fig. 3B). 
 The transmembrane domain of 
POMP10 contains the import signal - The 
localization of the different POMP10-GFP 
fusions was analyzed by IF as well as by 
isolation of crude mitochondrial fractions 
using digitonin extraction (37). Moreover, 
in order to test whether the 
mitochondrially localized fusion proteins 
are stably inserted into the OM, we 
performed carbonate extraction at pH 10.8 
and 11.5, respectively. This treatment 
disrupts protein-protein interactions but 
should not interfere with protein-lipid 
interactions. Insolubility after carbonate 
extraction at high pH is used as an 
operational definition for integral 
membrane proteins (38).  
 Fig. 4A shows that the full length 
POMP10-GFP fusion is correctly localized 
to mitochondria and behaves as an integral 
membrane protein (Fig. 5A). However, if 
the N-terminal transmembrane domain is 
deleted the POMP10-GFP fusion becomes 
soluble at low digitonin concentration and 
it accumulates outside mitochondria in a 
punctate-like pattern as evidenced by IF 
(Fig. 4B). The complementary fusion 
protein in which the transmembrane 
domain including the positively charged 
flanking residues was directly fused to the 
GFP on the other hand was correctly 
localized and inserted into the OM (Fig. 
4C and Fig. 5B). 
 The import signal of POMP10 
does not depend on positively charged 
amino acids - Further GFP variants that 
were tested either had the three N-terminal 
positively charged amino acids that flank 
the transmembrane domain (Fig. 4D), or 
the four positively charged lysines that 
flank the region C-terminally (Fig. 4E), or 
both (Fig. 4F), replaced by serines. All 
these POMP10-GFP fusions are still 
mitochondrially localized as evidenced by 
IF which results in a staining pattern that 
is congruent with the mitochondrial 
marker ATOM40. Moreover, like the full 
length POMP10, all these variants are 
recovered in a crude mitochondrial 
fraction obtained by digitonin extraction 
(Fig. 4D, 4E, 4F, right panel). However, 
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the carbonate extraction experiments in 
Fig. 5C, D, E show that replacing the 
positive charges by neutral ones on either 
side of the membrane-spanning domain 
causes a fraction of each of the POMP10-
GFP fusions to be released into the 
supernatant. The soluble fraction becomes 
larger at higher pH and/or if both sides of 
the membrane-spanning domain carry 
neutral residues (Fig. 5E), indicating that 
in the absence of positively charged 
flanking amino acids the transmembrane 
domain, while still targeted to the 
mitochondrial OM, is less efficiently 
inserted into or anchored in the lipid 
bilayer. 
 Overexpression of most of the 
truncated POMP10-GFP constructs (Fig. 
4D, 4E, 4F) that are targeted to 
mitochondria altered the morphology of 
the mitochondrial network as evidenced by 
enlarged sections that stain positive for 
mitochondrial marker proteins. All of 
these cell lines also grew more slowly, 
albeit to different extents, when expressing 
GFP fusion proteins (Fig. 6). This suggests 
that the altered mitochondrial morphology 
affects the overall fitness of the cells. 
However, the mechanism by which 
overexpression of the POMP10 
membrane-spanning domain and its 
mutant derivatives when fused to GFP 
affect mitochondrial morphology remains 
to be elucidated. 
 Negatively charged flanking 
sequences abolish the POMP10 import 
signal - While the membrane-spanning 
domain of POMP10-GFP is still targeted 
to mitochondria if the flanking positively 
charged amino acids are replaced by 
neutral ones (Fig. 4F), targeting is 
abolished if the transmembrane flanking 
regions are lost or if the positive residues 
are replaced by negatively charged 
glutamates (Fig. 4G, 4H). IF analysis 
shows that the resulting POMP10-GFP 
fusions appear in part to be localized to 
discrete structures that do not overlap with 
the mitochondrial marker ATOM40. 
Moreover, the protein is released into the 
supernatant at low concentration of 
digitonin. 
 In vivo biogenesis of POMP10 
depends on pATOM36 - Having identified 
the signal that targets POMP10 to the 
mitochondrial OM, we wanted to 
investigate which protein factors might 
mediate its biogenesis. The mitochondrial 
OM of T. brucei contains three protein 
complexes involved in mitochondrial 
protein import. The most important one is 
the ATOM complex, the pore-forming 
component of which is the β-barrel protein 
ATOM40 (32-34). As a functional 
analogue of the TOM complex it is 
required for import of essentially all 
mitochondrial proteins. Insertion of β-
barrel protein from the IMS side into the 
OM requires the SAM complex, the pore-
forming component of which is the β-
barrel protein SAM50 (39). Finally, there 
is the trypanosomatid-specific protein 
pATOM36 which dynamically associates 
with the ATOM complex (35). Recent 
work has shown that pATOM36 mediates 
the biogenesis of a number of OM proteins 
including subunits of the ATOM complex 
(36). In order to test the involvement of 
the three protein complexes in the 
targeting and import of POMP10, we 
expressed the full length version of the 
protein fused to GFP in tetracycline-
inducible ATOM40, Sam50 and 
pATOM36 RNAi cell lines, respectively. 
Using IF the localization of the GFP-
tagged fusion protein was analyzed in the 
three RNAi cell lines. Cells that had been 
induced with tetracycline for one day 
served as a control since the GFP-tagged 
fusion protein is already expressed but the 
RNAi effects are not visible yet. At this 
early time point of induction the staining 
pattern of the POMP10-GFP fusion 
protein coincided in all three cell lines 
with the mitochondrial marker (Fig. 7A). 
After three days of tetracycline induction 
all cell lines showed a growth arrest (Fig. 
7B) which has been described before 
(33,35,39). Moreover, as expected if 
mitochondrial protein import is abolished 
the morphology of mitochondria is 
drastically altered (Fig. 7A) (40). 
However, in the ATOM40 and the Sam50 
RNAi cell lines, despite the aberrant 
morphology of the organelles, the 
localization pattern of the POMP10-GFP 
fusion was essentially identical to the 
mitochondrial markers. This indicates that 
ablation of neither of the two proteins 
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affects POMP10 biogenesis. In contrast, 
ablation of pATOM36 caused 
accumulation of POMP10-GFP outside 
mitochondria as evidenced by the diffuse 
and punctate signal that only partially 
overlapped with the mitochondrial marker 
(Fig. 7A).  
 Fig. 7C shows immunoblots for 
the three RNAi cell lines. RNAi directed 
against pATOM36 leads to a rapid 
ablation of the protein. There is a decrease 
of ATOM14 and ATOM46 whose 
biogenesis has previously been shown to 
depend on pATOM36 (36). The levels of 
ATOM40, ATOM69 and VDAC however 
remain constant, except for a slight drop 
that is observed after 4 days of induction 
(Fig. 7C, left panel). As expected 
ATOM40 is early and efficiently 
downregulated in the ATOM40-RNAi cell 
line. The same is seen for the ATOM 
complex subunits ATOM14 and 
ATOM46. Moreover, we see 
downregulation of ATOM69 and VDAC. 
The level of pATOM36 however remains 
constant throughout induction and only 
slightly decreases at the latest time point 
(Fig. 7C, middle panel). RNAi of Sam50 
finally leads to ablation of the two β-barrel 
proteins VDAC and ATOM40. As a 
consequence of the latter a decline of 
ATOM14 and ATOM46, and to a lesser 
extent of ATOM69, is also observed. The 
level of pATOM36 on the other hand 
remains essentially constant (Fig. 7C, right 
panel). Finally, elongation factor 1a 
(EF1a) which serves as a cytosolic control 
is not affected in any of the three cell 
lines.  
 In summary, these results illustrate 
that pATOM36-RNAi has the most 
restricted effects on the tested proteins. 
Most importantly the ATOM complex 
subunits are much less reduced than when 
ATOM40 gets ablated. Yet it is in 
pATOM36-RNAi cell line that cytosolic 
accumulation of POMP10-GFP is 
observed. This confirms that pATOM36, 
but neither the ATOM complex nor 
Sam50, are required for the correct 
localization of POMP10. 
 It could be expected that in the 
absence a functional mitochondrial OM 
insertion machinery the POMP10-GFP 
might be directed to the ER. Fig. 8 shows 
that this is not the case since in the 
absence of pATOM36 only very little of 
the staining corresponding to the 
POMP10-GFP fusion protein overlaps 
with the ER.  
 All above mentioned RNAi cell 
lines expressing full length POMP10-GFP 
were also analyzed by extraction with low 
concentrations of digitonin. In Fig. 7D the 
resulting total, mitochondria-enriched 
pellet and supernatant fractions are 
analyzed on immunblots probed for the 
POMP10-GFP fusion protein as well as 
for EF1α and lipoamid dehydrogenase 
(LipDH) that serve as cytosolic and 
mitochondrial markers, respectively. 
Whereas in cell lines ablated for ATOM40 
and SAM50 the POMP10-GFP fusion 
protein is quantitatively recovered in the 
mitochondria-enriched pellet, a fraction of 
the protein is released into the supernatant 
in the absence of pATOM36. This 
indicates that the mitochondrial 
localization of POMP10 depends on 
pATOM36. The same is observed not only 
for the full length POMP10 fusion protein, 
but also if only the membrane-spanning 
domain is fused to GFP (ΔGFP(33-560)) 
(Fig. 7E). 
 In vitro biogenesis of POMP10 
depends on pATOM36 - In order to 
confirm that pATOM36 plays an 
important role in the biogenesis of 
POMP10 we performed in vitro insertion 
experiments. To that end we used the 
POMP10 variant, in which the membrane-
spanning domain was directly fused to 
GFP (GFP(Δ33-560)) and whose in vivo 
biogenesis was shown to depend on 
pATOM36 (Fig. 7D). Thus, the substrate 
was in vitro translated in the presence of 
[35S]methionine using reticulocyte lysate 
and subsequently incubated with 
mitochondria isolated from either 
uninduced cells or from cells ablated for 
pATOM36. To measure insertion of the 
protein into the mitochondrial OM, the 
reisolated organelles were extracted with 
sodium carbonate at pH 11.5 and the 
resulting pellets were analyzed by 
SDS/PAGE analysis (36). Fig. 9A shows a 
time-dependent increase of the radioactive 
substrate protein in the carbonate insoluble 
pellet fractions of organelles that stem 
 6	
from uninduced cells, indicating the 
substrate is inserted into the OM. 
However, in mitochondria isolated from 
pATOM36-ablated cells much less 
insertion is observed. Thus, as observed in 
vivo, pATOM36 facilitates the in vitro 
insertion of POMP10-GFP(Δ33-560) into 
the mitochondrial OM. Interestingly, 
another pATOM36 substrate, ATOM46, 
behaved differently in the same assay (Fig. 
9B, middle panel). As described 
previously in the case of ATOM46 
pATOM36 mediates the integration of the 
protein into the ATOM complex rather 
than its insertion into the membrane (36). 
Fig. 9B (right panel) finally shows that 
membrane insertion of POMP10-
GFP(Δ33-560) is not affected in 
mitochondria ablated for ATOM40, even 
though in these organelles the levels of all 
ATOM subunits are lower than in the 
induced pATOM36 cell line (Fig. 7C) 
(32,36).  
 
DISCUSSION 
 In a recent study we have purified 
the OM of T. brucei and shown by a 
combination of protein abundance 
profiling and label-free quantitative mass 
spectrometry that its proteome consists of 
82 different proteins of which 42 contain 
one or more putative transmembrane 
domains (7). Among them seven proteins 
are bioinformatically predicted to be 
signal-anchored. In the present study we 
selected one of these proteins, termed 
POMP10, to investigate its biogenesis 
pathway.  
 Using a protease protection assay 
we confirmed that POMP10 is indeed a 
signal-anchored protein. In a first series of 
experiments we showed that the targeting 
signal of POMP10 for the OM is confined 
to the predicted membrane-spanning 
domain and a few flanking residues. We 
then demonstrated that the positively 
charged flanking residues can be replaced 
by neutral ones without affecting 
mitochondrial localization. However, if 
the positively charged flanking residues 
are replaced by negatively charged ones or 
deleted, targeting of the protein is 
abolished. 
 The targeting sequence of signal-
anchored proteins has previously been 
analyzed in yeast, humans and plants. In 
all three systems the signal was confined 
to a membrane-spanning domain of 
"moderate" hydrophobicity which 
however did not show sequence similarity 
between different signal-anchored proteins 
of the same or different species (13,14). 
Moreover, whereas for human and plant 
signal-anchored proteins a C-terminal 
positively charged flanking region was an 
additional requirement for OM targeting 
(13,41,42), this was not the case for the 
corresponding proteins of yeast since their 
positively charged residues could be 
replaced by neutral ones without affecting 
the targeting (14,15). While in the latter 
case the protein was still correctly 
targeted, its integration into the OM 
membrane was weakened.  
 The targeting signal of 
trypanosomal POMP10 conforms to this 
picture. As in the other systems it consists 
of a transmembrane domain with moderate 
hydrophobicity that includes N-terminal 
and C-terminal flanking regions 
containing positively charged residues. 
However, as in yeast but unlike in plants 
and humans, these residues are not 
essential for mitochondrial targeting but 
do influence the strength of the interaction 
with the OM. 
 Yeast and humans belong to the 
eukaryotic supergroup of the Opisthokonts 
and plants to the supergroup of the 
Archeaplastidae, which represent two of 
the six main branches of the eukaryotic 
phylogenetic tree (43). T. brucei is a 
member of the supergroup of the 
Excavates which are essentially unrelated 
to Archeaplastidae and Opisthokonts. The 
fact that the general features of the 
targeting signal for signal-anchored OM 
proteins are similar in all three systems 
suggests that they may be conserved in all 
eukaryotes. 
 While the targeting signal of 
signal-anchored mitochondrial OM 
proteins has been investigated in fungi, 
mammals and plants our knowledge of the 
components required for the biogenesis of 
these proteins is restricted to the two 
fungal species S. cerevisiae and 
Neurospora crassa. It has been shown in 
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yeast that neither the SAM complex nor 
the import receptors, Tom20 and Tom70, 
both of which are themselves signal-
anchored proteins, are required for the 
biogenesis of signal-anchored OM 
proteins. Moreover, it has been 
demonstrated that the pore protein Tom40 
can be blocked without affecting the 
import of signal-anchored proteins, 
although Tom20 still requires Tom40 for 
its biogenesis (9-11). Finally, a protein 
complex consisting of Mim1 and Mim2 
has been characterized that is involved in 
import and assembly of at least some 
signal-anchored OM proteins 
(22,23,44,45). Mim1 and Mim2 were also 
shown to be involved in the insertion 
and/or assembly of some tail-anchored as 
well as multi membrane-spanning 
proteins. However, the mechanism by 
which Mim1 and Mim2 exert their 
function remains to be investigated.   
 In trypanosomes we showed that 
membrane insertion in vivo and in vitro of 
the signal-anchored POMP10 did neither 
require ATOM40 nor Sam50, the pore 
forming components of the ATOM and the 
SAM complexes. However, biogenesis of 
POMP10 did depend on pATOM36 a 
trypanosomatid-specific OM protein. A 
recent study has shown that pATOM36 
has a dual localization. Similar to 
ATOM40 it is localized all over the OM, 
however, in contrast to ATOM40 it is also 
enriched at the tripartite attachment 
complex (TAC), the structure that links the 
mitochondrial DNA to the basal body of 
the flagellum. The dual localization of 
pATOM36 reflects its dual function in: i) 
the assembly of OM proteins, including 
most subunits of the ATOM complex (32) 
and ii) the segregation of the replicated 
mitochondrial genome (35,36).  
 Ablation of pATOM36 resulted in 
the accumulation of a fraction of POMP10 
outside mitochondria in vivo and much 
reduced membrane insertion in vitro, 
suggesting that the protein is required for 
targeting and/or insertion of the protein 
into the OM. This is different to the 
previously analyzed substrates of 
pATOM36, such as ATOM complex 
subunits, which in the absence of the 
pATOM36 were still inserted into the 
membrane but not assembled into high 
molecular weight complexes (36).  
 It is tempting to speculate that the 
kinetoplastid-specific pATOM36 might be 
a functional analogue of fungal Mim1 and 
2 which were shown to be involved in the 
insertion and/or assembly of some signal-
anchored OM proteins in yeast 
(22,23,44,45). Thus, while the targeting 
signals for signal-anchored proteins appear 
to be conserved in all eukaryotes, this is 
not the case for the factors mediating their 
biogenesis. There is no sequence similarity 
between pATOM36 and Mim1/Mim2 and 
the molecular weights of the two sets of 
proteins are also very different: 
pATOM36, 36 kDa; Mim1, 13 kDa; 
Mim2, 11 kDa. The only recognizable 
motif that is shared between the two 
groups of proteins are two GxxxG(A) 
motifs in their predicted transmembrane 
domains. However this motif is quite 
frequent in transmembrane domains. 
 In summary our results show the 
existence of evolutionary distinct 
biogenesis factors for signal-anchored 
proteins in the different eukaryotic 
supergroups. Moreover, the fact that Mim1 
and Mim2 are absent from mammals, 
which as the fungi belong to the 
Opisthokonts, indicates that there might be 
different biogenesis factors even within 
the same supergroup. Identification of 
biogenesis factors for signal-anchored OM 
proteins in different phylogenetic groups is 
important, as it may allow the 
identification of shared traits between 
them which will help to define the 
fundamental biochemical features 
mandatory for their function.  
 
EXPERIMENTAL PROCEDURE 
 Production of transgenic cell lines 
- Transgenic procyclic cell lines are based 
on T. brucei 29-13 (46). Cells were grown 
at 27°C in SDM79 supplemented with 
10% (v/v) FCS. All plasmids are based on 
the pLew100 expression vector in which 
the phleomycine resistance gene has been 
replaced by a puromycine resistance gene 
(47) and in which the ORF coding for 
enhanced GFP was inserted. PCR 
amplicons corresponding to the different 
variants of POMP10 (Tb927.11.13180) 
were cloned into this enhanced GFP 
 8	
expression vector to allow expression of 
C-terminally tagged variants. Cells were 
grown to mid exponential phase and 
transfected with the corresponding 
linearized plasmid (48), followed by 
selection in medium containing 
puromycine. DNA constructs were 
verified by sequencing. RNAi constructs 
targeting ATOM40 (33), SAM50 (49) and 
pATOM36 (35) have been described 
elsewhere  
 Immunoblotting - Protein samples 
were separated by SDS-PAGE and 
transferred onto nitrocellulose membranes 
(GE Healthcare). Membranes were 
blocked in 5% (w/v) milk in PBS-Tween 
(137 mM CaCl2, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, 0.1% (v/v) 
Tween-20, pH 7.4) and incubated 
overnight, with the appropriate antibody at 
4°C. Monoclonal primary antibodies used 
were: mouse anti-GFP (Roche, dilution 
1:1’000) and mouse anti-EF1α (Merck 
Millipore, dilution 1:10’000). Polyclonal 
primary antibodies produced in rabbits 
were: anti-VDAC (dilution 1:1’000) (50), 
anti-ATOM40 (dilution 1:1’000) (32), 
anti-Cyt c (dilution 1:1’000) (7). and anti-
TIM9 (1:20) (7) and rabbit anti-LipDH 
(1:10’000) (provided by L. Krauth-Siegel, 
Heidelberg University). Detection of the 
antibodies was done with an Odyssey 
Infrared imaging system using IRDye 
secondary antibodies (Li-COR 
Biosciences, dilution 1:20’000). 
 Immunofluoresence - The cells 
were collected, washed in PBS, and 
subsequently resuspended in ice-cold 
buffer. All further steps were performed in 
a wet chamber. Cells were fixed for 10 
minutes in freshly made 4% para-
formaldehyde in PBS (pH 7.2) and rinsed 
with ice-cold PBS. Cells were incubated in 
PBS containing 0.2% Triton-X100 for 5 
minutes. Primary antibodies were rabbit 
anti-VDAC (1:100), rabbit anti-ATOM40 
(1:1’000), rabbit anti-ATOM69 (1:3) (32) 
and rabbit anti-BIP (1:5’000). Cy3-
conjugated goat anti-rabbit (dilution 
1:500) was used as a secondary antibody. 
Cells were rinsed in ice-cold buffer, post-
fixed in cold methanol and mounted with 
VectaShield containingDAPI (Vector 
Laboratories). Fluorescence images were 
taken with Leica fluorescence microscope 
(Leica Microsystems). Images stacks were 
recorded and deconvoluted using LAS X 
software from Leica (Leica 
Microsystems).  
 Digitonin extractions - Cell 
membranes were lysed by resuspension of 
108 cells in SoTe buffer (20 mM Tris-HCL 
pH 7.5, 0.6 M sorbitol and 2 mM EDTA) 
containing 0.015% (w/v) digitonin 
followed by differential centrifugation. 
This yielded a mitochondria-enriched 
pellet and a fraction enriched for cytosolic 
proteins (37). All samples were analyzed 
by immunoblot experiments. 
 Carbonate extractions - 
Mitochondria-enriched fractions were 
resuspended in 160 µl of 100 mM Na2CO3 
pH 11.5 or 10.8. Thereof, 80 µl were 
removed and mixed with 20 µl 5x SDS 
loading buffer and boiled to serve as the 
‘total’ sample. The remaining 80 µl were 
incubated on ice for 10 minutes and 
centrifuged (1000’000g, 4°C, 10 min). The 
supernatant was transferred to a new tube 
and 20 µl 5x SDS loading buffer was 
added prior to boiling. The pellet was 
resuspended in 80 µl of 100mM Na2CO3 
and 20 µl 5x SDS loading buffer was 
added prior to boiling. All samples were 
analysed by SDS-PAGE. 
 Protease protection assay - 
Isotonically isolated mitochondria (25µg) 
from cells (51,52) expressing POMP10-
GFP were resuspended in 20 mM Tris-
HCl pH 7.2, 15 mM KH2PO4, 20 mM 
MgSO4, 0.6 M sorbitol in a total volume 
of 50 µl in presence of proteinase K (10 
mg/ml) containing or not 0.5% (v/v) 
Triton-X100 followed by incubation on ice 
for 15 min. Reactions were stopped by 
adding PMSF 
(phenylmethylsulfonylfluorid) at 5mM and 
mitochondria were centrifuged (6’800 g, 
4°C), resuspended in SDS-loading buffer 
and boiled. 
 In vitro insertion of proteins into 
the mitochondrial OM - The membrane 
isertion assay was done exactly as 
described in (36). 35S-Met-labelled 
POMP10-GFP(Δ33-560) and ATOM46 
were synthesized using the TNT T7 Quick 
for PCR in vitro translation kit (Promega). 
For the coupled transcription and 
translation, gel-eluted PCR-fragments 
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were used that consisted of the T7 RNA 
polymerase promoter fused to the 
complete ORF of the corresponding 
substrates.   
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FIGURE LEGENDS 
 
FIGURE 1. RNAi-mediated ablation of POMP10 does neither affect growth nor 
mitochondrial morphology. (A) Growth curve of uninduced (-Tet) and induced (+Tet) 
POMP10-RNAi cell line. Inset, Northern blot of the POMP10 mRNA after two days of RNAi 
induction. Ethidiumbromide-stained gel showing the rRNAs served as a loading control. (B) 
Immunofluorescence analysis of induced (2 d and 7 d) and uninduced RNAi cells. Cells were 
stained with ATOM40 antiserum as a mitochondrial marker (red) and 4′,6-diamidin-2-
phenylindol (DAPI) to highlight nuclear and mitochondrial DNA (blue). 
 
FIGURE 2. POMP10 is a signal-anchored mitochondrial OM protein. (A) Upper panel, 
outline of the mitochondrial purification scheme. Lower panel, immunoblot analysis of the 
indicated fractions of a mitochondrial purification from the cell line expressing full length 
POMP10 that is C-terminally tagged with GFP (POMP10-GFP). The fractions (5 µg each) 
depicted are: whole cells (wc), cytosol (cyto), crude mitochondria (crude) and pure 
mitochondria (pure). The samples were separated by SDS-PAGE, blotted and probed for: 
GFP; the mitochondrial markers ATOM40, cytochrome C (Cyt c) and lipoamid 
dehydrogenase (LipDH) and the cytosolic marker elongation factor 1α (EF1α). (B) 
Immunoblots of a protease protection assay using gradient-purified structurally intact 
mitochondria isolated from cell lines expressing POMP10-GFP analyzed by anti-GFP 
antiserum. Additions of proteinase K and of Triton X-100 are indicated. The OM protein 
ATOM69 serves as a control OM protein. The IMS protein Tim9 and the matrix protein 
mtHsp70 serve as controls for OM integrity. In the presence of Triton X-100 mtHsp70 is 
degraded to a protease resistant fragment. 
 
FIGURE 3. Transgenic cell lines expressing POMP10-GFP fusions. (A) FL, full length GFP 
fusion. For the other fusion proteins the extent of the deletions (Δ) as well as the positions that 
were replaced with either serine (S) or glutamate (E) are indicated on the left. Amino acid 
sequences of the signal-anchor domains in the indicated POMP10-GFP fusion proteins are 
shown in the middle. The predicted membrane-spanning domain is underlined. The serine and 
glutamate residues that were used to replace the positively charged flanking amino acids are 
indicated in bold. The symbols used for the different GFP constructs are shown on the right: 
black line, cytosolic domain; box, signal-anchor domain; large white box, predicted 
membrane-spanning domain; small black boxes, positively charged flanking sequence(s); 
small white boxes, uncharged flanking sequence(s); small grey boxes, negatively charged 
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flanking sequences. (B) Immunoblot analysis of total cellular extracts from equal cell 
numbers of the parental strain T. brucei 29-13 and the indicated transgenic cell lines 
expressing the various POMP10-GFP fusion proteins were probed for GFP and EF1α, which 
serves as a loading control. 	
FIGURE 4. Characterization of the targeting signal in POMP10. IF analysis of the indicated 
POMP10-GFP fusion proteins (A-H, left columns) in procyclic forms of transgenic T. brucei 
(A-H, middle column). Samples were probed for GFP and the mitochondrial marker 
ATOM40, respectively. An overlap of both signals is also shown (Merge). Bar, 10µm. Crude 
digitonin-based cell fractionation analysis (A-H, right column) of cell lines expressing the 
indicated POMP10-GFP fusion proteins. Total cellular extract (T), crude mitochondrial 
fraction (P) and digitonin-extracted cytosolic fraction (S). LipDH and EF1α serve as 
mitochondrial and cytosolic markers, respectively. 
 
FIGURE 5. Carbonate extractions at high pH of membrane-associated POMP10-GFP 
fusion proteins. Immunoblots of equal cells equivalents of total (T), pellet (P) and 
supernatant (S) fractions of a carbonate-extracted crude mitochondrial pellet obtained by 
digitonin extraction of cells expressing the indicated POMP10-GFP variants (A-E). The 
extraction was performed both pH 10.8 and pH 11.5 and immunoblots were analyzed by anti-
GFP. ATOM40 and Cyt c serve as markers representing an integral and peripheral membrane 
protein, respectively.  
 
FIGURE 6. Expression of some of the truncated POMP10-GFP fusions interferes with 
growth. Growth curves of uninduced (black line) and induced (red line) cell lines expressing 
the indicated recombinant POMP10-GFP fusion proteins. All analyzed cell lines show an 
altered mitochondrial morphology (see Fig. 4D, 4E, 4F). Insets, immunoblots confirming 
expression of the GFP fusion poteins. VDAC serves as loading control.  
 
FIGURE 7. In vivo biogenesis of POMP10 depends on pATOM36. (A) IF analysis of full 
length POMP10 that is C-terminally tagged with GFP (GFP(FL): green) and mitochondrial 
marker proteins (VDAC and ATOM69: red) in tetracycline-inducible pATOM36 (left 
panels), ATOM40 (middle panels) and SAM50 (right panels) RNAi cell lines. Time of 
induction in days (d) is indicated at the top. Bar, 10µm. (B) Growth curves of tetracycline-
inducible pATOM36 (left panels), ATOM40 (middle panels) and SAM50 (right panels) 
RNAi cell lines that co-express full length POMP10-GFP and that were used in (A). (C) Equal 
cell equivalents of the same RNAi cell lines shown in (A) (left panel, pATOM36; middle 
panel, ATOM40; right panel, SAM50) were analyzed for the presence or absence of 
pATOM36, ATOM40, ATOM14, ATOM46, ATOM69, VDAC and cytosolic EF1a using 
immunoblots. Time of RNAi induction is indicated at the top of each panel. (D) Crude 
digitonin-based cell fractionation analysis of the same cell lines shown in (A). and (B). Total 
cellular extract (top panels), crude mitochondrial fraction (pellet, middle panels) and 
digitonin-extracted cytosolic fraction (SN, bottom panels) were probed for POMP10-GFP 
(GFP(FL)). LipDH and EF1α serve as mitochondrial and cytosolic markers, respectively. (E) 
Same as (D) but a tetracycline-inducible pATOM36 RNAi cell line that co-expresses the 
POMP10 fusion protein in which the transmembrane domain including the positively charged 
flanking residues was directly fused to the GFP was analyzed. 
 
FIGURE 8. Ablation of pATOM36 does not cause mislocalization to the ER. IF analysis of 
full length POMP10 that is C-terminally tagged with GFP (POMP(FL): green) and the ER 
marker protein BiP (red) in the tetracycline-inducible pATOM36 RNAi cell line. Time of 
induction in days (d) is indicated at the top. Bar, 10µm. 
 
FIGURE 9. In vitro biogenesis of POMP10 depends on pATOM36 (A) Left panel, in vitro 
insertion assay of the 35S-Met-labeled POMP10-GFP(Δ33-560) using mitochondria isolated 
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from the uninduced (-Tet) and induced (+Tet, 2 days) procyclic pATOM36-RNAi cell line. 
Incubation times are indicated at the top. The pellet fraction of an alkaline carbonate 
extraction were separated by SDS-PAGE and analyzed by autoradiography. Lower panel, 
section of the Coomassie-stained gel serve as loading controls. Graph on the right, 
quantification of triplicate experiments shown on the left. Standard errors are indicated. (B) 
Graph of triplicate in vitro insertion assays (9 min time point) using isolated mitochondria of 
uninduced and induced pATOM36 and ATOM40 RNAi cell lines, respectively. The tested 
substrates are indicated at the top. Standard errors are indicated. The SDS-gels representing a 
typical experiments including their corresponding loading controls are indicated below the 
graphs. Bottom panels, immunoblot confirming the specific downregulation of pATOM36 
and ATOM40 in the respective RNAi cell lines. 
 
 
 
TABLES 	
Name	of	server	 position	of	predicted	
transmembrane	
domains	
number	of	predicted	
transmembrane	
domains	DAS	 12-18,	230-233	 2	HMMTOP	 8-25	 1	MEMSAT	 8-25	 1	PRED-TMR	 8-25	 1	SPLIT	 227-248	 1	TMHMM	 7-25	 1	TOPCONS	 7-25	 1		
Table	1.	Prediction	of	transmembrane	domains	using	the	indicated	prediction	tools.	
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